SecBot SecBot
SC 13G/A ·Filed Nov 13, 2026

XGN

EXAGEN INC.
NEUTRAL
Impact 2/10
Horizonimmediate Processed4d ago SEC0001140361-26-043757
Passive stake amendment
Actionable Insight • Neutral

Monitor for any future conversion to a Schedule 13D or stake increase above 5%, which would signal a shift from passive to active intent. The unchanged passive stake has no immediate trading implications.

DirectionNeutral
Confidencehigh
Horizonimmediate

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

NMSIC Co-Investment Fund, L.P. filed an amendment to its Schedule 13G disclosing beneficial ownership of 863,958 shares of Exagen Inc. (XGN), representing 3.39% of outstanding shares as of October 28, 2026. The stake is unchanged from the prior filing, and the investor remains below the 5% threshold, indicating no material change in passive positioning.

Key Financial Metrics

Stake
3.39%
Investor
NMSIC Co-Investment Fund, L.P.

Key Facts

  • NMSIC Co-Investment Fund, L.P. reported 863,958 shares of Exagen Inc. common stock, representing 3.39% of shares outstanding.
  • The percentage is based on 25,513,497 shares outstanding as of November 3, 2026, per the company's Form 10-Q.
  • Sun Mountain Capital Partners, L.L.C. is the general partner of NMSIC and may be deemed to share beneficial ownership.
  • The filing is an amendment to a prior Schedule 13G; no change in stake size or percentage is indicated compared to the prior filing.

Financial Impact

No financial impact; stake is unchanged and below 5%.

Risk Factors

  • No material risks identified from this filing.

Market Snapshot

Exchange
Nasdaq
Sector
Services-Medical Laboratories
Analyst Consensus
92% bullish (12 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G/A Filing (Primary)0001140361-26-043757
Document: 0001140361-26-043757-index.html0001140361-26-043757
Document: 0001140361-26-043757.txt0001140361-26-043757

Track record

17 reports on XGN

Performance horizon

6 of 6 bullish or bearish reports moved the stock their way by T+20. Best: +67.09% at T+60 after the May 11, 2026 report. 7 of 7 went positive at some point.

Filters
  1. Nov 17, 2026today 424B5 Bearish 5/10 Entry $3.69 Now $3.76 −1.90% settles Dec 17
  2. Nov 13, 20263d ago SC 13G/A Neutral 3/10 Entry $4.33 Now $3.76 −13.16% settles Dec 15
  3. Nov 13, 20264d ago SC 13G/A Neutral 2/10 Viewing Entry $5.02 Now $3.76 −25.10% settles Dec 15
  4. Nov 12, 20265d ago Insider Buy Neutral 4/10 Entry $4.41 Now $3.76 −14.74% settles Dec 11
  5. Nov 10, 20266d ago Insider Buy Mixed 4/10 Entry $5.04 Now $3.76 −25.32% settles Dec 10
  6. Nov 10, 20267d ago S-3 Bearish 5/10 Entry $5.26 Now $3.76 +28.52% settles Dec 9
  7. Nov 10, 20267d ago Press Release Neutral 4/10 Entry $5.26 Now $3.76 −28.52% settles Dec 9
  8. Oct 20, 202628d ago Insider Cluster Mixed 4/10 Entry $7.41 Now $3.76 −49.26% due Nov 17
  9. Aug 4, 202615w ago 8-K Bullish 7/10 Entry $6.45 to $7.12 Now $3.76 −41.71% ▲ +10.39% +11.63% vs SPY
  10. May 11, 202627w ago 8-K Bullish 6/10 No price data
Showing 10 of 17

US Market Status

Market Closed · Opens Wed (16h 52m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 13, 2026